Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Prevalence of Inflammatory Bowel Disease (Ibd) in Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis Publisher



Nasirzadeh A1 ; Jahanshahi R2 ; Ghajarzadeh M3 ; Mohammadi A4 ; Moghadasi AN1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran
  2. 2. Department of Neurology, University of Medical Sciences, Gorgan, Iran
  3. 3. Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Universal Council of Epidemiology (UCE), Universal Scientific Education and Research Network (USERN), Tehran University of Medical Sciences, Tehran, Iran

Source: International Journal of Preventive Medicine Published:2023


Abstract

Background: This systematic review and meta-analysis aim to update the pooled prevalence of Inflammatory bowel disease (IBD) in patients with multiple sclerosis (MS). Methods: Two researchers independently and systematically searched PubMed, Scopus, EMBASE, Web of Science, and google scholar. They also searched for references of the included studies, and conference abstracts that were published up to September 2021. Results: The literature search revealed 5719 articles, after deleting duplicates 3616 remained. Finally, 17 studies were included. The pooled prevalence of IBD in MS was 1% (I 2 = 96.3%, P < 0.001). The pooled odds ratio of developing IBD in MS cases was 1.36 (95% CI: 1.1-1.6) (I 2 = 58.3, P = 0.01). Conclusions: The results of this systematic review and meta-analysis show that the pooled prevalence of IBD in MS patients was 1% and the pooled odds ratio of developing IBD in MS cases was 1.36. © 2023 International Journal of Preventive Medicine | Published by Wolters Kluwer - Medknow.
Related Docs
View other Related Docs
1. Multiple Sclerosis and Ulcerative Colitis: A Systematic Review and Meta-Analysis, Multiple Sclerosis Journal - Experimental# Translational and Clinical (2023)
2. A Presentation of Ulcerative Colitis After Rituximab Therapy in a Patient With Multiple Sclerosis and Literature Review, Multiple Sclerosis and Related Disorders (2018)
3. From Multiple Sclerosis to Organ-Specific Autoimmune Disorders: Insights Into the Molecular and Clinical Implications of Comorbidity, Molecular Neurobiology (2025)
4. Elucidating the Significance of Zonulin in the Pathogenesis of Chronic Inflammatory Disorders: Emphasis on Intestinal Barrier Function and Tight Junction Regulation, Current Medicinal Chemistry (2025)
5. Risk of Common Neurological Disorders in Adult Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis, Inflammatory Bowel Diseases (2024)
6. The Prevalence of Cancer in Patients With Multiple Sclerosis (Ms) Who Were Under Treatment With Natalizumab (Tysabri): A Systematic Review and Meta-Analysis, International Journal of Preventive Medicine (2023)
7. Medical History Risk Factors in Primary Progressive Multiple Sclerosis: A Case-Control Study, Current Journal of Neurology (2021)
8. Medical History and Multiple Sclerosis: A Population-Based Incident Case-Control Study, Neuroepidemiology (2019)
Experts (# of related papers)
View all Related Experts
Mohammad Ali Sahraian (4)
Abdolreaza Naser Moghadasi (3)
Other Related Docs
9. Validity and Reliability of the Persian Version of the Perception De La Scle’Rose En Plaques Et De Ses Pousse’Es Questionnaire Evaluating Multiple Sclerosis-Related Quality of Life, International Journal of Preventive Medicine (2016)